Related by context. Frequent words. (Click for all words.) 63 BAY #-# 60 Amrubicin 60 ocrelizumab 59 Asentar 59 angiogenesis inhibitor 59 pertuzumab 59 tanezumab 58 Yervoy 57 aflibercept 57 Atiprimod 57 anticancer therapy 57 Diamyd ® 57 deforolimus 57 Azedra 57 LY# [003] 57 IND submission 56 cangrelor 56 motavizumab 56 ICA # 56 phase IIb 56 lupus nephritis 56 HGS ETR1 56 Telcyta 56 Xyotax 56 anticancer compound 56 tofacitinib 56 Nexavar ® 56 tesetaxel 56 iclaprim 56 midstage study 56 phase IIa 55 squalamine 55 Pivotal Phase III 55 romidepsin 55 Phase IIa trial 55 Folotyn 55 axitinib 55 ASA# 55 RGB # 55 integrase inhibitor 55 alogliptin 55 ELND# 55 Desmoteplase 55 glufosfamide 55 vicriviroc 55 Phase 2a trial 55 Alemtuzumab 55 GVAX 54 Treanda 54 Phase III 54 phenoxodiol 54 SinuNase 54 eltrombopag 54 romiplostim 54 Promacta 54 Advexin 54 PXD# 54 Phase 2b study 54 Phase IIa clinical 54 TELCYTA 54 MOZOBIL 54 registrational trial 54 HER2 positive metastatic breast 54 Chrysalin 54 tanespimycin 54 muraglitazar 54 methylnaltrexone 53 vandetanib 53 T DM1 53 Phase III clinical 53 Avastin bevacizumab 53 Zerenex 53 myelodysplastic syndromes 53 immunomodulator 53 sapacitabine 53 PLX# 53 acute decompensated heart 53 tyrosine kinase inhibitor 53 relapsing remitting multiple sclerosis 53 LymphoStat B 53 OXi# 53 Torisel 53 PARP inhibitors 53 Hycamtin 53 hormone refractory prostate cancer 53 temsirolimus 53 Phase 2b trial 53 Phase 1b trial 53 Cushing Syndrome 53 nitazoxanide 53 maribavir 53 MIRCERA 53 Phase 2a clinical 53 confirmatory Phase III 53 phase 2a 53 secondary hyperparathyroidism 53 Phase IIb trial 52 IV melanoma 52 organ transplant rejection 52 Phase 2b clinical 52 taranabant